20452 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more sulfur atoms in the same ring
USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION
#2COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
#3USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION
#4METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#5COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF THEIR USE IN REVERSING CANCER CHEMORESISTANCE
#6T-cell lymphoma treatments
#7Use of methylation inhibitors for the treatment of autoimmune diseases
#8Dithio ETP derivatives
#9Use of H3K9me3 modulation for enhancing cognitive function
#10Pharmaceutical composition comprising epidithiodioxopiperazine compound or derivative thereof, or pharmaceutically acceptable salt thereof, for preventing or treating pulmonary hypertension
#11Dithio ETP derivatives
#12Use of H3K9me3 modulation for enhancing cognitive function
#13METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#14Epidithiodioxopiperazine compound or its derivatives, and the use thereof
#15COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#16Use of H3K9me3 modulation for enhancing cognitive function
#17ETP derivatives
#18COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#19COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#20Epidithiodioxopiperazine compound or its derivatives, and the use thereof
#21ETP derivatives
#22COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
#23ETP derivatives
#24EPIDITHIODIKETOPIPERAZINE COMPOUNDS, COMPOSITIONS, AND METHODS
#25METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#26Reactivation of HIV-1 gene expression to treat persistent HIV infection
#27Inhibition of hypoxia-inducible factor activity with extracts
#28Verticillin A Inhibition of Histone Methyltransferases
#29COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#30Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
#31SELECTIVE PROTEASOME INHIBITORS FOR TREATING DIABETES
#32COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#33Tumor treatment with gliotoxin derivatives
#34Treatment for liver disease
#35Use of Inhibitors of the Ubiquitin Proteasome Pathway as a Method of Increasing Contractility of the Heart
#36Treatment for liver disease